XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Shareholders' Equity (Deficit): Stock Options Activity (Details) - Stock options - USD ($)
3 Months Ended 12 Months Ended
Apr. 01, 2023
Mar. 26, 2022
Dec. 31, 2022
Number of Shares      
Outstanding at the beginning of the period (in shares) 361,628    
Granted (in shares) 4,500    
Exercised (in shares) (3,518)    
Outstanding at the end of the period (in shares) 362,610   361,628
Exercisable at the end of the period (in shares) 216,436    
Weighted Average Exercise Price      
Outstanding at the beginning of the period (in dollars per share) $ 164.70    
Granted (in dollars per share) 291.10    
Exercised (in dollars per share) 167.81    
Outstanding at the end of the period (in dollars per share) 166.24   $ 164.70
Exercisable at the end of the period (in dollars per share) $ 134.42    
Weighted Average Remaining Contractual Life (years)      
Outstanding 6 years 2 months 8 days   6 years 4 months 24 days
Exercisable at the end of the period 4 years 6 months 25 days    
Intrinsic Value      
Outstanding at the beginning of the period $ 26,688,183    
Outstanding at the end of the period 55,912,100   $ 26,688,183
Exercisable at the end of the period $ 40,259,300    
Weighted average assumptions and results used in estimation of fair value of options granted      
Risk free interest rate (as a percent) 4.13% 1.88%  
Expected life (years) 6 years 6 years  
Expected volatility (as a percent) 28.43% 26.64%  
Dividend yield (as a percent) 3.25% 4.21%  
Option fair value (in dollars per share) $ 69.41 $ 33.92